Dubroff: Companies play let’s make a deal but they don’t always win
There’s no question that the current wave of corporate mergers is reshaping big chunks of the corporate landscape on the Central Coast. But all mergers are not created equal and history suggests that more than half of mergers involving large publicly traded companies don’t really work out at all. For a look at what’s working Read More →
Santa Barbara’s QAD reports $15.5 million net loss
Santa Barbara manufacturing software company QAD reported a $15.5 million net loss, or 84 cents per diluted Class A share for the fiscal year ended Jan. 31, as a result of a valuation allowance related to deferred tax assets. The valuation allowance was connected to the company’s investments in cloud technology, the March 9 earnings Read More →
Semtech reports skyrocketing net income
Camarillo semiconductor company Semtech announced $8 million in net income for the fourth quarter of its fiscal year 2017, up from $1.25 million for the same quarter last year. Full fiscal year 2017 net income came to $54.66 million, more than three times its net income for 2016. Earnings per share during the quarter rose Read More →
Amgen declares $1.15 per share dividend
The board of directors for Thousand Oaks biotechnology company Amgen declared a $1.15 per share dividend March 3 for the second quarter of 2017. The dividend will be paid on June 8 to all stockholders of record as of the close of business on May 17. The company has a market cap of $130.1 billion Read More →
AeroVironment reports drop in revenues
AeroVironment, a Monrovia-based aircraft systems company with operations in Simi Valley, announced a drop in revenues for its third quarter fiscal 2017, ending in a $2.2 million net loss. Revenues for the quarter fell from $67.6 million the prior year to $53.2 million, mainly from its unmanned aircraft division. Gross margin also decreased 27 percent Read More →
Interlink net income grows on higher revenues
Story updated at 11 a.m. March 6: Interlink Electronics reported a 67 percent year-over-year increase in net income March 3, bringing in $924,000 for the fourth quarter 2016 and $2.89 million for the year. Revenues were almost flat to the fourth quarter of 2015 at $2.78 million, while fiscal year revenues increased 13 percent to Read More →
Stellar Biotechnologies gets immunotherapy manufacturing contract
Port Hueneme immunotherapy company Stellar Biotechnologies announced an exclusive multi-year supply agreement with Taiwanese manufacturer Amaran Biotechnology. The agreement coincides with late-stage clinical studies for an immunotherapy called Adagloxad Simolenin, which treats cancers including metastatic breast cancer. The two companies will also develop the manufacturing process for Stellar’s Keyhole Limpet Hemocyanin conjugated vaccine, made from Read More →
